Targeted weight reduction using Sibutramine

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21230%2F10%3A00172146" target="_blank" >RIV/68407700:21230/10:00172146 - isvavai.cz</a>

Alternative codes found

RIV/60162694:G44__/10:00002408

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Targeted weight reduction using Sibutramine

Original language description

Obesity is a serious chronic disease resulting from positive energy balance. Obesity is also an independent risk factor for the development of non-communicable widespread disorders. The endpoint of the trial was a targeted reduction of excessive body weight in 99 individuals with BMI over 30 or 27 kg/m2 respectively. Three-month weight reduction therapy was based on the restriction of energy intake and pharmacotherapy by Sibutramine hydrochloride monohydrate (Sibutramine) 10 mg/person/day. Results: three-month targeted therapy resulted in statistically significant decrease of BMI, body weight, body fat and waist circumference. The reduction improved lipid profile and resulted in the decrease of systolic and diastolic blood pressure. Heart rate increased only insignificantly.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

JC - Computer hardware and software

OECD FORD branch

—

Project

—

Continuities

Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2010

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

TRANSLATIONAL BIOMEDICINE

ISSN

2172-0479

e-ISSN

—

Volume of the periodical

1

Issue of the periodical within the volume

3

Country of publishing house

ES - SPAIN

Number of pages

4

Pages from-to

—

UT code for WoS article

—

EID of the result in the Scopus database

—